GPC3 and neoplasm: On the other hand, miR-4510 was considered to be a tumor suppressor as it suppressed the Wnt/β-catenin pathway by targeting the glypican-3 (GPC3) oncogene, thereby decreasing HB cell line and HuH6 cell viability [9].